Latest Articles
Health strategy bids to stop women being ‘ignored, gaslit and humiliated’ in NHS - The Independent
Health strategy bids to stop women being ‘ignored, gaslit and humiliated’ in NHS The Independent
Published: April 14, 2026, 9:30 p.m.
The Fallout With Jack, Jenni and Adam: Five Takeaways From Lena Dunham’s Memoir ‘Famesick’ - The Hollywood Reporter
The Fallout With Jack, Jenni and Adam: Five Takeaways From Lena Dunham’s Memoir ‘Famesick’ The Hollywood Reporter
Published: April 14, 2026, 2:58 p.m.
How NHS ‘medical misogyny’ is failing female patients - The Independent
How NHS ‘medical misogyny’ is failing female patients The Independent
Published: April 14, 2026, 2:47 p.m.
Adenomyosis symptoms as BBC star ‘conditioned’ to accept pain - The Mirror
Adenomyosis symptoms as BBC star ‘conditioned’ to accept pain The Mirror
Published: April 14, 2026, 10:26 a.m.
Adenomyosis symptoms as BBC star ‘conditioned’ to accept pain - OK! Magazine
Adenomyosis symptoms as BBC star ‘conditioned’ to accept pain OK! Magazine
Published: April 14, 2026, 10:26 a.m.
Jes Burns and Brook Herbert win national award for reporting on cancer research - Oregon Public Broadcasting - OPB
Jes Burns and Brook Herbert win national award for reporting on cancer research Oregon Public Broadcasting - OPB
Published: April 13, 2026, 11:38 p.m.
Naima T. Joseph, MD, MPH, on why US maternal mortality is “a complex web of factors” - Contemporary OB/GYN
Naima T. Joseph, MD, MPH, on why US maternal mortality is “a complex web of factors” Contemporary OB/GYN
Published: April 13, 2026, 6:17 p.m.
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer - TipRanks
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer TipRanks
Published: April 13, 2026, 12:29 p.m.
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
Biontech prepares FDA application after strong phase II results in endometrial cancer medwatch.com
Published: April 13, 2026, 12:14 p.m.
GSK (NYSE: GSK) reports Mo-Rez data in ovarian, endometrial cancer - Stock Titan
GSK (NYSE: GSK) reports Mo-Rez data in ovarian, endometrial cancer Stock Titan
Published: April 13, 2026, 10:23 a.m.
Link copied to clipboard!